Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response
Splinter, T.A.; Denis, L.; Scher, H.I.; Schröder, F.H.; Dalesio, O.
Progress in Clinical and Biological Research 303: 541-547
1989
ISSN/ISBN: 0361-7742 PMID: 2675011 Document Number: 327132
Document emailed within 1 workday
Related Documents
Scher, H.I. 1990: Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvant Seminars in Oncology 17(5): 555-565Kubota, T.; Choda, Y.; Morito, T.; Miyake, S.; Ishida, M.; Sato, D.; Sumitani, D.; Nakano, K.; Harano, M.; Matsukawa, H.; Ojima, Y.; Idani, H.; Shiozaki, S.; Okajima, M. 2017: A Case of Duodenal Invasive Advanced Gastric Cancer in which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1470-1472
Timovska, Y.O.; Pivnyuk, V.M.; Oliynichenko, G.P.; Anikushko, M.F.; Zachartseva, L.M.; Chekhun, V.F. 2009: Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer Experimental Oncology 31(4): 231-236
Cui, J.; Yang, L.; Guo, L.; Shao, Y.; Li, N.; Zhang, H. 2015: Surgical management of patients with pathologic complete response in the primary tumor after neoadjuvant chemotherapy for rectal cancer Zhonghua Zhong Liu Za Zhi 37(6): 456-460
Eshita, Y.; Ogawa, F. 2013: A case of advanced gastric cancer with bulky lymph node metastases responding to S-1/CDDP neoadjuvant chemotherapy and leading to less invasive surgery and a pathologically complete response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(6): 793-795
Akilli, H.; Rahatli, S.; Tohma, Y.A.; Karakas, L.A.; Altundag, O.; Ayhan, A. 2018: Effect of increased number of neoadjuvant chemotherapy cycles on tumor resectability and pathologic response in advanced stage epithelial ovarian cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 23(7): 111-115
Fair, W.R. 1991: Neoadjuvant therapy in invasive bladder cancer. Problems and pitfalls Urologic Clinics of North America 18(3): 539-542
Trifard, F.; Chrétien, Y.; Vallantin, X.; Collet, C.; Lachand, A.T.; Dufour, B. 1988: [Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients Annales d'Urologie 22(3): 216-219
Liu, Y.; Zhang, X.; Yu, F.; Liu, J.; Zhang, M.; Zhang, S.; Hao, X.; Zhang, J. 2014: Prognostic significance of Ki-67 expression before and after neoadjuvant chemotherapy in different biological breast cancer phenotypes Zhonghua Zhong Liu Za Zhi 36(9): 671-676
Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction Ginekologia Polska 79(2): 108-114
Káposztás, Z.; Cseke, L.ás.ó; Kalmár, K.; Horváth, O.P.ét. 2002: Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response Magyar Sebeszet 55(5): 321-324
Hui, R.; Zhang, J.; Fan, Y. 2008: Clinical significance of pathological response in the breast cancer after neoadjuvant chemotherapy Zhonghua Yi Xue Za Zhi 88(14): 961-964
Scher, H.I.; Splinter, T.A. 1990: Chemotherapy for invasive bladder cancer: introduction Seminars in Oncology 17(5): 515-516
Yabusaki, H.; Nashimoto, A.; Tanaka, O. 2002: A complete response after neoadjuvant chemotherapy for advanced gastric cancer with esophageal invasion Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(1): 119-123
Sun, B.; Song, S.-t.; Wu, S.-k.; Jiang, Z.-f.; Wang, T.; Zhang, S.-h.; Zhao, Y.-b.; Yu, C.-z.; Li, X.-b.; Yang, T.; Li, G.-j. 2009: Comparison of response evaluation methods of neoadjuvant chemotherapy in breast cancer patients Zhonghua Zhong Liu Za Zhi 31(10): 783-785
Boonjunwetwat, D.; Prueksadee, J.; Sampatanukul, P.; Chatamra, K. 2005: Does color Doppler ultrasound vascularity predict the response to neoadjuvant chemotherapy in breast cancer? Journal of the Medical Association of Thailand 88(10): 1367-1372
Suematsu, Y.; Yamagishi, S.; Saito, H.; Takahashi, M.; Nakayama, M.; Fukabori, M.; Morita, A.; Wakabayashi, K.; Itoh, Y. 2016: A Case of Advanced Gastric Cancer with a Pathological Complete Response after Neoadjuvant Chemotherapy(S-1/Oxaliplatin) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2225-2227
Kemmochi, A.; Inagawa, S.; Akashi, Y.; Inagaki, Y.; Satomi, K.; Ohkohchi, N. 2016: A Case of Advanced Gastric Cancer with a Complete Response to S-1 Neoadjuvant Chemotherapy in an Elderly Patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(1): 115-119
Tian, Y. 2012: Attach importance to the chemotherapy of muscle invasive bladder cancer Zhonghua Yi Xue Za Zhi 92(6): 363-365
Evangelista, L.; Cervino, A.R.; Michieletto, S.; Saibene, T.; Orvieto, E.; Bozza, F.; Ghiotto, C. 2017: Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 61(2): 205-215